PDB :
Fibroblast growth factor receptors (FGFRs) are recognized therapeutic targets in cancer. Structures released on 25th February describe insights underpinning the impact of mutations on these proteins on drug efficacy.
The structures are described by Bunney et al. in EBioMedicine
